Go Pro
→ Rickards Predicts: Trump to buy tiny $2 stock? (From Paradigm Press) (Ad)tc pixel Free PYC Stock Alerts

Physiomics (PYC) Competitors

Physiomics logo
GBX 0.51 -0.01 (-0.97%)
As of 11:43 AM Eastern
Compare

PYC vs. BVX, OBD, TLM, NFX, and BNR

Should you buy Physiomics stock or one of its competitors? Physiomics's main competitors and comparable companies include BiVictriX Therapeutics (BVX), Oxford BioDynamics (OBD), Talisman Metals (TLM), Nuformix (NFX), and Burning Rock Biotech (BNR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Physiomics compare to BiVictriX Therapeutics?

BiVictriX Therapeutics (LON:BVX) and Physiomics (LON:PYC) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.

BiVictriX Therapeutics has a beta of -0.73, indicating that its share price is 173% less volatile than the broader market. Comparatively, Physiomics has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market.

BiVictriX Therapeutics has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Physiomics' return on equity of -89.43% beat BiVictriX Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
BiVictriX TherapeuticsN/A -103.99% -62.99%
Physiomics -50.92%-89.43%-76.38%

Physiomics has higher revenue and earnings than BiVictriX Therapeutics. Physiomics is trading at a lower price-to-earnings ratio than BiVictriX Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BiVictriX TherapeuticsN/AN/A-£2.67M-£0.04N/A
Physiomics£953.01K2.43-£922.82K-£0.15N/A

In the previous week, Physiomics had 1 more articles in the media than BiVictriX Therapeutics. MarketBeat recorded 1 mentions for Physiomics and 0 mentions for BiVictriX Therapeutics. BiVictriX Therapeutics' average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
BiVictriX Therapeutics Neutral
Physiomics Neutral

30.8% of BiVictriX Therapeutics shares are held by institutional investors. Comparatively, 0.8% of Physiomics shares are held by institutional investors. 42.6% of BiVictriX Therapeutics shares are held by company insiders. Comparatively, 20.7% of Physiomics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Physiomics beats BiVictriX Therapeutics on 6 of the 11 factors compared between the two stocks.

How does Physiomics compare to Oxford BioDynamics?

Physiomics (LON:PYC) and Oxford BioDynamics (LON:OBD) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

Physiomics has higher earnings, but lower revenue than Oxford BioDynamics. Physiomics is trading at a lower price-to-earnings ratio than Oxford BioDynamics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Physiomics£953.01K2.43-£922.82K-£0.15N/A
Oxford BioDynamics£1.20M4.31-£103.52M-£0.20N/A

Physiomics has a net margin of -50.92% compared to Oxford BioDynamics' net margin of -825.61%. Physiomics' return on equity of -89.43% beat Oxford BioDynamics' return on equity.

Company Net Margins Return on Equity Return on Assets
Physiomics-50.92% -89.43% -76.38%
Oxford BioDynamics -825.61%-451.74%-56.23%

In the previous week, Physiomics and Physiomics both had 1 articles in the media. Physiomics' average media sentiment score of 0.00 equaled Oxford BioDynamics'average media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Physiomics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Oxford BioDynamics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

0.8% of Physiomics shares are owned by institutional investors. Comparatively, 11.6% of Oxford BioDynamics shares are owned by institutional investors. 20.7% of Physiomics shares are owned by company insiders. Comparatively, 15.6% of Oxford BioDynamics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Physiomics has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market. Comparatively, Oxford BioDynamics has a beta of 0.42, meaning that its share price is 58% less volatile than the broader market.

Summary

Physiomics beats Oxford BioDynamics on 6 of the 11 factors compared between the two stocks.

How does Physiomics compare to Talisman Metals?

Physiomics (LON:PYC) and Talisman Metals (LON:TLM) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

In the previous week, Physiomics had 1 more articles in the media than Talisman Metals. MarketBeat recorded 1 mentions for Physiomics and 0 mentions for Talisman Metals. Physiomics' average media sentiment score of 0.00 equaled Talisman Metals'average media sentiment score.

Company Overall Sentiment
Physiomics Neutral
Talisman Metals Neutral

0.8% of Physiomics shares are held by institutional investors. Comparatively, 1.4% of Talisman Metals shares are held by institutional investors. 20.7% of Physiomics shares are held by company insiders. Comparatively, 95.2% of Talisman Metals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Physiomics has higher revenue and earnings than Talisman Metals. Physiomics is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Physiomics£953.01K2.43-£922.82K-£0.15N/A
Talisman MetalsN/AN/A-£1.35M£12.390.58

Physiomics has a beta of 1.05, suggesting that its share price is 5% more volatile than the broader market. Comparatively, Talisman Metals has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market.

Talisman Metals has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Talisman Metals' return on equity of -32.71% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
Physiomics-50.92% -89.43% -76.38%
Talisman Metals N/A -32.71%3.70%

Summary

Talisman Metals beats Physiomics on 7 of the 11 factors compared between the two stocks.

How does Physiomics compare to Nuformix?

Nuformix (LON:NFX) and Physiomics (LON:PYC) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment.

Nuformix has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Nuformix's return on equity of -83.53% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
NuformixN/A -83.53% -17.20%
Physiomics -50.92%-89.43%-76.38%

Nuformix has a beta of 1.519, meaning that its stock price is 52% more volatile than the broader market. Comparatively, Physiomics has a beta of 1.05, meaning that its stock price is 5% more volatile than the broader market.

In the previous week, Physiomics had 1 more articles in the media than Nuformix. MarketBeat recorded 1 mentions for Physiomics and 0 mentions for Nuformix. Nuformix's average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
Nuformix Neutral
Physiomics Neutral

0.1% of Nuformix shares are held by institutional investors. Comparatively, 0.8% of Physiomics shares are held by institutional investors. 7.5% of Nuformix shares are held by insiders. Comparatively, 20.7% of Physiomics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Nuformix has higher earnings, but lower revenue than Physiomics. Nuformix is trading at a lower price-to-earnings ratio than Physiomics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NuformixN/AN/A-£383.40K-£0.03N/A
Physiomics£953.01K2.43-£922.82K-£0.15N/A

Summary

Nuformix beats Physiomics on 6 of the 11 factors compared between the two stocks.

How does Physiomics compare to Burning Rock Biotech?

Burning Rock Biotech (LON:BNR) and Physiomics (LON:PYC) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Burning Rock Biotech has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Burning Rock Biotech's return on equity of 0.00% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
Burning Rock BiotechN/A N/A N/A
Physiomics -50.92%-89.43%-76.38%

In the previous week, Physiomics had 1 more articles in the media than Burning Rock Biotech. MarketBeat recorded 1 mentions for Physiomics and 0 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
Burning Rock Biotech Neutral
Physiomics Neutral

Burning Rock Biotech has higher earnings, but lower revenue than Physiomics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Burning Rock BiotechN/AN/AN/AN/AN/A
Physiomics£953.01K2.43-£922.82K-£0.15N/A

0.8% of Physiomics shares are owned by institutional investors. 20.7% of Physiomics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Physiomics beats Burning Rock Biotech on 4 of the 7 factors compared between the two stocks.

Get Physiomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PYC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PYC vs. The Competition

Export
MetricPhysiomicsBiotechnology IndustryHealthcare SectorLON Exchange
Market Cap£2.31M£3.99B£7.20B£2.89B
Dividend Yield6.20%3.61%2.53%6.17%
P/E Ratio-3.4012.25272.63364.82
Price / Sales2.431,349.92620.8183,676.90
Price / Cash4.21105.2976.9827.89
Price / Book2.4516.1912.856.75
Net Income-£922.82K-£22.72M£3.47B£5.89B
7 Day Performance6.25%-1.18%-0.22%-0.78%
1 Month Performance10.15%12.75%8.04%2.38%
1 Year Performance12.09%53.86%25.08%22.66%

Physiomics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PYC
Physiomics
N/AGBX 0.51
-1.0%		N/A+0.6%£2.31M£953.01KN/A10
BVX
BiVictriX Therapeutics
N/AN/AN/AN/A£8.25MN/AN/A17
OBD
Oxford BioDynamics
N/AGBX 0.12
-2.4%		N/A-76.8%£5.15M£1.20MN/A45
TLM
Talisman Metals
N/AGBX 7.50
+7.1%		N/AN/A£4.81MN/A0.615
NFX
Nuformix
N/AGBX 0.16
+2.5%		N/A+71.0%£4.25MN/AN/A3

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:PYC) was last updated on 9/2/2026 by MarketBeat.com Staff.
From Our Partners
Under $1… and Wall Street already knows about it
On August 19th, Bitcoin exploded 23% in a matter of days… triggering nearly $3 billion in short liquidations, ...
Crypto 101 Media | Sponsoredtc pixel
Gold Explorer Sits Between Barrick’s Nevada Giants
Barrick Mining has spent decades building one of Nevada's richest gold districts, anchored by Fourmile, Goldru...
Wall Street Logic | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
A weekly dividend fund holding Nvidia and Palantir
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...
Investors Alley | Sponsoredtc pixel
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
Why Boston Ships In Natural Gas It Already Has at Home
A tanker called the Iberica Knutsen once sailed 2,272 miles from Trinidad and Tobago to deliver liquefied natu...
Porter & Company | Sponsoredtc pixel
#1 Stock to Own as Trump Launches Historic Mission Backing "Medical AI"
The federal government is throwing its full support behind a new class of AI technology, in what's being calle...
Stansberry Research | Sponsoredtc pixel